Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,596Revenue $M7,528Net Margin (%)6.8Altman Z-Score2.8
Enterprise Value $M14,381EPS $3.5Operating Margin %13.3Piotroski F-Score5
P/E(ttm)21.1Beneish M-Score-2.7Pre-tax Margin (%)10.4Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %7.1Quick Ratio1.1Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %3.6Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow17.7y-y EBITDA Growth Rate %-26.2ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %1.9PEG5.9ROE % (ttm)12.3Less Shares Outstanding y-yN
Payout Ratio %42.0Shares Outstanding M144ROIC % (ttm)8.8Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXBrian Rogers 2015-06-30 Sold Out -0.49%$69.89 - $79.6
($73.88)
$ 73.81-0%Sold Out0
DGXRobert Olstein 2015-03-31 Sold Out -0.48%$66.27 - $77.69
($71.61)
$ 73.813%Sold Out0
DGXBrian Rogers 2015-03-31 Reduce-0.3%$66.27 - $77.69
($71.61)
$ 73.813%Reduce 41.67%1,750,000
DGXHOTCHKIS & WILEY 2015-03-31 Sold Out -0.23%$66.27 - $77.69
($71.61)
$ 73.813%Sold Out0
DGXJohn Rogers 2015-03-31 Add0.11%$66.27 - $77.69
($71.61)
$ 73.813%Add 33.49%515,958
DGXDavid Dreman 2015-03-31 Reduce-0.06%$66.27 - $77.69
($71.61)
$ 73.813%Reduce 33.54%21,554
DGXChris Davis 2015-03-31 Reduce-0.02%$66.27 - $77.69
($71.61)
$ 73.813%Reduce 1.68%5,068,925
DGXJoel Greenblatt 2015-03-31 Reduce-0.02%$66.27 - $77.69
($71.61)
$ 73.813%Reduce 35.63%56,784
DGXCharles Brandes 2015-03-31 Reduce-0.01%$66.27 - $77.69
($71.61)
$ 73.813%Reduce 6.12%174,714
DGXRobert Olstein 2014-12-31 Reduce-0.18%$57.71 - $68.1
($63.08)
$ 73.8117%Reduce 28.05%59,000
DGXCharles Brandes 2014-12-31 Buy 0.18%$57.71 - $68.1
($63.08)
$ 73.8117%New holding186,113
DGXRichard Pzena 2014-12-31 Sold Out -0.14%$57.71 - $68.1
($63.08)
$ 73.8117%Sold Out0
DGXHOTCHKIS & WILEY 2014-12-31 Reduce-0.13%$57.71 - $68.1
($63.08)
$ 73.8117%Reduce 38.25%983,900
DGXJoel Greenblatt 2014-12-31 Reduce-0.09%$57.71 - $68.1
($63.18)
$ 73.8117%Reduce 62.94%88,219
DGXHOTCHKIS & WILEY 2014-09-30 Reduce-0.19%$59.28 - $64.08
($61.73)
$ 73.8120%Reduce 36.86%1,593,262
DGXJoel Greenblatt 2014-09-30 Add0.14%$59.28 - $64.08
($61.73)
$ 73.8120%Add 5330.13%238,057
DGXChris Davis 2014-06-30 Add0.8%$55.5 - $61.75
($58.56)
$ 73.8126%Add 4465.97%4,672,681
DGXRichard Pzena 2014-06-30 Reduce-0.18%$55.5 - $61.75
($58.56)
$ 73.8126%Reduce 55.66%431,100
DGXRobert Olstein 2014-06-30 Reduce-0.14%$55.5 - $61.75
($58.56)
$ 73.8126%Reduce 18.00%82,000
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 73.8126%Reduce 94.26%4,384
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PREVOZNIK MICHAEL ESVP & General Counsel 2015-03-03Sell3,261$71.163.72view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-02-17Sell488$71.413.36view
GUINAN MARKSenior Vice President & CFO 2015-02-17Sell280$71.742.89view
STANZIONE DANIELDirector 2015-02-11Sell8,000$70.974view
PFEIFFER GARY MDirector 2015-02-04Sell8,000$72.431.91view
WILENSKY GAIL RDirector 2015-02-04Sell8,000$72.342.03view
ZIEGLER JOHN BDirector 2015-02-03Sell8,000$71.882.69view
BONGIORNO THOMAS FVP and Corporate Controller 2015-02-02Sell3,000$71.53.23view
BONGIORNO THOMAS FVP and Corporate Controller 2014-11-18Sell10,000$6415.33view
Cohen Jon RSVP and Chief Medical Officer 2014-11-17Sell160,029$63.1316.92view

Quarterly/Annual Reports about DGX:

News about DGX:

Articles On GuruFocus.com
Brian Rogers Buys Occidental Petroleum, Tyco In Q2 Jul 16 2015 
Vermillion (VRML) Ovarian Cancer Test Mega-deal; Papa Murphy's Holdings (FRSH) and Wix (WIX) Strong Mar 18 2015 
Charles Brandes' Top Buys During Q4 Feb 11 2015 
A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
DGX: A Healthy Diagnosis Oct 08 2014 
The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 

More From Other Websites
QUEST DIAGNOSTICS INC Files SEC form 10-Q, Quarterly Report Jul 30 2015
Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance... Jul 29 2015
Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance... Jul 29 2015
Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies Jul 29 2015
Quest Diagnostics attracting bulls Jul 28 2015
Your first trade for Tuesday, July 28 Jul 27 2015
Fast Money Final Trade: GMCR, DGX, JPM & X Jul 27 2015
Illumina, Inc. Earnings Analysis: By the Numbers Jul 27 2015
Edited Transcript of DGX earnings conference call or presentation 23-Jul-15 12:30pm GMT Jul 23 2015
Quest Diagnostics (DGX) Earnings Report: Q2 2015 Conference Call Transcript Jul 23 2015
Quest Diagnostics Tops Earnings, Revenues Lag Estimates - Analyst Blog Jul 23 2015
Quest Diagnostics (DGX) Beat on Q2 Earnings; Revenues Lag - Tale of the Tape Jul 23 2015
Quest Diagnostics Inc Earnings Call scheduled for 8:30 am ET today Jul 23 2015
Q2 2015 Quest Diagnostics Inc Earnings Release - Before Market Open Jul 23 2015
QUEST DIAGNOSTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2015
Quest Diagnostics Reports Second Quarter 2015 Financial Results Jul 23 2015
What's in Store at Quest Diagnostics (DGX) this Earnings? - Analyst Blog Jul 21 2015
Sonora Quest Laboratories Empowers Patients Across Arizona to Take Control of Their Health with... Jul 16 2015
A second FDA approval frees Theranos to do a blood test outside lab Jul 16 2015
Quest Diagnostics To Release Second Quarter 2015 Financial Results On July 23 Jul 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK